Allergy Relief D — Class III drug recall D-0073-2023
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2022-12-07, distributed nationwide. Failed dissolution specifications
| Recall number | D-0073-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2022-11-21 |
| Classified | 2022-11-30 |
| Reported by FDA | 2022-12-07 |
| Terminated | 2024-08-28 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 49032-0273-20, 49032-0273-30 |
| Lot numbers | AC2203133A, AC2203133B |
| Expiration dates | 2024-01 |
Product
Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India
Reason for recall
Failed dissolution specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0073-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.